Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
$154.72
-2.5%
$145.85
$120.80
$230.63
$169.88B1.268.74 million shs8.44 million shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$529.24
+1.4%
$563.19
$476.49
$1,211.20
$57.14B0.31879,349 shs951,512 shs
Walmart Inc. stock logo
WMT
Walmart
$94.20
-0.7%
$95.79
$66.41
$105.30
$751.76B0.6917.94 million shs18.67 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
0.00%+3.67%+1.46%-2.04%-28.15%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.00%+7.30%-10.95%-21.99%-48.94%
Walmart Inc. stock logo
WMT
Walmart
0.00%-3.34%-4.13%+7.61%+40.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
4.9505 of 5 stars
3.25.04.23.43.32.51.9
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4.8799 of 5 stars
4.44.01.72.33.41.71.9
Walmart Inc. stock logo
WMT
Walmart
4.8566 of 5 stars
3.55.03.31.82.92.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
2.39
Hold$189.8822.72% Upside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.85
Moderate Buy$836.4858.05% Upside
Walmart Inc. stock logo
WMT
Walmart
2.97
Moderate Buy$106.5013.06% Upside

Current Analyst Ratings Breakdown

Latest QCOM, WMT, and REGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$950.00 ➝ $800.00
6/9/2025
Walmart Inc. stock logo
WMT
Walmart
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$105.00 ➝ $115.00
6/9/2025
Walmart Inc. stock logo
WMT
Walmart
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$105.00 ➝ $110.00
6/9/2025
Walmart Inc. stock logo
WMT
Walmart
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$102.00 ➝ $103.00
6/9/2025
Walmart Inc. stock logo
WMT
Walmart
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$115.00
6/5/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$633.00 ➝ $560.00
6/4/2025
Walmart Inc. stock logo
WMT
Walmart
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$105.00 ➝ $107.00
6/2/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$700.00 ➝ $650.00
6/2/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$800.00 ➝ $600.00
6/2/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$958.00 ➝ $755.00
5/30/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
$42.29B4.02$9.01 per share17.17$24.30 per share6.37
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$14.09B4.06$34.75 per share15.23$268.50 per share1.97
Walmart Inc. stock logo
WMT
Walmart
$685.09B1.10$4.01 per share23.51$12.13 per share7.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
$10.14B$9.8216.5315.692.0125.94%39.51%18.65%7/30/2025 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.41B$39.2813.8313.922.3431.07%16.32%12.76%7/30/2025 (Estimated)
Walmart Inc. stock logo
WMT
Walmart
$15.51B$2.3439.0931.194.422.85%21.87%7.84%8/21/2025 (Estimated)

Latest QCOM, WMT, and REGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2026
Walmart Inc. stock logo
WMT
Walmart
$0.58$0.61+$0.03$0.56$164.53 billion$165.61 billion
4/30/2025Q2 2025
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
$2.82$2.85+$0.03$2.52$10.58 billion$10.98 billion
4/29/2025Q1 2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$8.83$8.22-$0.61$7.27$3.40 billion$3.03 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
$3.562.30%N/A36.25%23 Years
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$3.520.67%N/A8.96%N/A
Walmart Inc. stock logo
WMT
Walmart
$0.941.00%N/A40.17%53 Years

Latest QCOM, WMT, and REGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/9/2025
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
quarterly$0.892.5%6/5/20256/5/20256/26/2025
5/20/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
quarterly$0.880.6%5/20/20255/20/20256/6/2025
5/3/2025
Walmart Inc. stock logo
WMT
Walmart
$0.23500.95%5/9/20255/12/20255/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
0.49
2.62
1.99
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.09
4.73
3.95
Walmart Inc. stock logo
WMT
Walmart
0.40
0.82
0.23

Institutional Ownership

CompanyInstitutional Ownership
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
74.35%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%
Walmart Inc. stock logo
WMT
Walmart
26.76%

Insider Ownership

CompanyInsider Ownership
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
0.08%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7.02%
Walmart Inc. stock logo
WMT
Walmart
45.58%
CompanyEmployeesShares OutstandingFree FloatOptionable
QUALCOMM Incorporated stock logo
QCOM
QUALCOMM
51,0001.10 billion1.11 billionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11,900107.97 million101.15 millionOptionable
Walmart Inc. stock logo
WMT
Walmart
2,300,0007.98 billion4.37 billionOptionable

Recent News About These Companies

Walmart Inc. stock logo
Ecommerce Stocks To Consider - June 15th
Walmart Inc. stock logo
Video Game Stocks To Follow Now - June 15th
Walmart Inc. stock logo
Best Outdoor Stocks To Watch Now - June 15th
Walmart Inc. stock logo
Top Home Improvement Stocks To Follow Today - June 14th
Walmart Inc. stock logo
Ecommerce Stocks To Watch Today - June 14th
Walmart Inc. stock logo
Video Game Stocks To Watch Today - June 14th
Walmart Inc. stock logo
Promising Outdoor Stocks To Research - June 14th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
QUALCOMM stock logo

QUALCOMM NASDAQ:QCOM

$154.72 -3.98 (-2.51%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$154.75 +0.03 (+0.02%)
As of 06/13/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QUALCOMM Incorporated engages in the development and commercialization of foundational technologies for the wireless industry worldwide. It operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on 3G/4G/5G and other technologies for use in wireless voice and data communications, networking, computing, multimedia, and position location products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of wireless products comprising products implementing CDMA2000, WCDMA, LTE and/or OFDMA-based 5G standards and their derivatives. The QSI segment invests in early-stage companies in various industries, including 5G, artificial intelligence, automotive, consumer, enterprise, cloud, IoT, and extended reality, and investments, including non-marketable equity securities and, to a lesser extent, marketable equity securities, and convertible debt instruments. It also provides development, and other services and related products to the United States government agencies and their contractors. The company was incorporated in 1985 and is headquartered in San Diego, California.

Regeneron Pharmaceuticals stock logo

Regeneron Pharmaceuticals NASDAQ:REGN

$529.24 +7.40 (+1.42%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$528.00 -1.24 (-0.23%)
As of 06/13/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Walmart stock logo

Walmart NYSE:WMT

$94.20 -0.63 (-0.66%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$94.52 +0.32 (+0.34%)
As of 06/13/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications. The company offers grocery and consumables, including dairy, meat, bakery, deli, produce, dry, chilled or frozen packaged foods, alcoholic and nonalcoholic beverages, floral, snack foods, candy, other grocery items, health and beauty aids, paper goods, laundry and home care, baby care, pet supplies, and other consumable items; fuel, tobacco and other categories. It is also involved in the provision of health and wellness products covering pharmacy, optical and hearing services, and over-the-counter drugs and other medical products; and home and apparel including home improvement, outdoor living, gardening, furniture, apparel, jewelry, tools and power equipment, housewares, toys, seasonal items, mattresses and tire and battery centers. In addition, the company offers consumer electronics and accessories, software, video games, office supplies, appliances, and third-party gift cards. Further, it operates digital payment platforms; and offers financial services and related products, including money transfers, bill payments, money orders, check cashing, prepaid access, co-branded credit cards, installment lending, and earned wage access. Additionally, the company markets lines of merchandise under private brands, including Allswell, Athletic Works, Equate, and Free Assembly. The company was formerly known as Wal-Mart Stores, Inc. and changed its name to Walmart Inc. in February 2018. Walmart Inc. was founded in 1945 and is based in Bentonville, Arkansas.